Comment by
biorun on Feb 22, 2022 12:28pm
You do know this is an R&D company you invested in. Licensing royalties revenues, upfront payments, and buyout potential. This is not a blue chip, nor is it a company with quarters earnings calls like Pfizer or Johnson and Johnson. These are their potential customers. Enough with the BS and whining please. Make a contribution.
Comment by
navajojoe on Feb 22, 2022 1:32pm
This post has been removed in accordance with Community Policy